+987.9%
MRNA vs STLD
+59.7%
+928.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | STLD | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -3.0% | +16.2% | +10.9% |
| 7D | +20.6% | -3.9% | +24.6% | +17.5% |
| 30D | +27.1% | -0.4% | +27.5% | +26.1% |
| 3M | +353.4% | -9.2% | +362.6% | +347.6% |
| 6M | +446.3% | +5.0% | +441.3% | +415.5% |
| YTD | +776.2% | +42.8% | +733.4% | +606.2% |
| 1Y | +987.9% | +60.1% | +927.8% | +640.3% |
| All | +987.9% | +59.7% | +928.2% | +640.3% |
Cumulative growth
Daily Returns
Daily percentage return beside STLD.
Daily Out/Under-Performance
Portfolio return minus STLD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STLD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded STLD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling